Different ways to move (Editor’s Note)
There are many ways that we can move to achieve our fitness goals. Everyone have a choice of CrossFit, TRX, yoga, zumba, weightlifting and many more. But the very basic…
Mundipharma’s painfocus(TM) Digital Platform Set to Revolutionise Pain Measurement and Management via Artificial Intelligence
Mundipharma joins forces with Singapore HealthTech Startup Biofourmis developing painfocus™ SINGAPORE, Aug. 6, 2018 /PRNewswire/ — Mundipharma has announced the development of painfocus™, a revolutionary new end-to-end pain management solution…
Tan Tock Seng Hospital, the Wound Healing Society Singapore and Zuellig Pharma team up to advance wound care expertise in Singapore
SINGAPORE, Aug. 6, 2018 /PRNewswire/ — A Memorandum of Understanding was signed on Friday 3 August by Tan Tock Seng Hospital (TTSH)’s Centre for Asian Nursing Studies (CANS), the Wound…
Boehringer Ingelheim achieves modest growth in the first half of 2018
Advances in research and development Half-year net sales of 8.6 billion euros Satisfactory currency-adjusted growth in all businesses Major investments in sites in Germany and France INGELHEIM, Germany, Aug. 1,…
Thailand Board of Investment to boost investment in Food Innopolis and EECi
BANGKOK, Aug. 1, 2018 /PRNewswire/ — The Thailand Board of Investment (BOI) has agreed to expand seven additional sites as “Food Innopolis”, aiming to create value-added agricultural products nationwide through…
IMPACT Therapeutics Raises $30 Million In Series C Financing
NANJING, China, Aug. 3, 2018 /PRNewswire/ — IMPACT Therapeutics, Inc. (IMPACT), a China-based clinical-stage biopharmaceutical company dedicated to the discovery and development of “best-in-class” medicine for the treatment of cancer…
China Biologic Reports Financial Results for the Second Quarter of 2018
— 2Q18 Total Sales Up 25.5% YoY and Non-GAAP Adjusted Net Income Down 2.8% YoY in RMB terms, or Total Sales Up 34.8% YoY to $120.4 Million and Net Income…
Ascletis’ NDA for Its All-oral HCV Treatment Accepted by CFDA
HANGZHOU, China and SHAOXING, China, Aug. 1, 2018 /PRNewswire/ — Ascletis announced today it has received the acceptance letter from the China Food and Drug Administration (CFDA) for Ravidasvir (RDV,…
BBB Announces Technology Behind a Mobile Cancer Analyzer ‘markB’ at AACC 2018 Annual Scientific Meeting
– Detection of cancer biomarkers within 10 minutes with a single drop of blood – markB is a point-of-care testing device, that can be used by anyone – After beginning…
VolitionRx’s First Research Use Only Product Is “On-The-Shelf” Today
ISNES, Belgium, Aug. 1, 2018 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced that its first product the “Total Nu.Q™ Assay” research use only (RUO) kit, is ready…
